Stay updated on Imatinib in Recurrent Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Imatinib in Recurrent Psoriasis Clinical Trial page.

Latest updates to the Imatinib in Recurrent Psoriasis Clinical Trial page
- Check6 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This change updates the page's revision tag and does not alter study content or functionality.SummaryDifference0.1%

- Check13 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2. This indicates a maintenance or patch release of the page and does not change the study content or eligibility details.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe study page now shows recruitment has ended ('No longer looking for participants'), and new help/navigation sections such as How to Read a Study Record, Common Questions, and How to Join a Study have been added.SummaryDifference0.5%

- Check34 days agoChange DetectedA new page revision tag appears at the bottom: Revision: v3.5.5, replacing Revision: v3.5.4, indicating an updated page build.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page now displays Revision: v3.5.4 instead of Revision: v3.5.3, indicating a small site version update. This does not modify the study details visible on the page.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page’s displayed site revision/version updated from **v3.5.2** to **v3.5.3**, indicating a platform release change rather than a modification to the study record content.SummaryDifference0.1%

Stay in the know with updates to Imatinib in Recurrent Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imatinib in Recurrent Psoriasis Clinical Trial page.